[1] Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.21492.
[2] den Hoed CM, Kuipers EJ. Gastric Cancer: How Can We Reduce the Incidence of this Disease?. Curr Gastroenterol Rep. 2016;18(7):34. doi:10.1007/s11894-016-0506-0.
[3] Berger H, Marques MS, Zietlow R, Meyer TF, Machado JC, Figueiredo C. Gastric cancer pathogenesis. Helicobacter. 2016;21 Suppl 1:34–38. doi:10.1111/hel.12338.
[4] Zhou J, Ma X, Bi F, Liu M. Clinical significance of circulating tumor cells in gastric cancer patients. Oncotarget. 2017;8(15):25713–25720. doi:10.18632/oncotarget.14879.
[5] Qi R, Wang DT, Xing LF, Wu ZJ. miRNA-21 promotes gastric cancer growth by adjusting prostaglandin E2. Eur Rev Med Pharmacol Sci. 2018;22(7):1929–1936. doi:10.26355/eurrev_201804_14717.
[6] Hu X, Zhang M, Miao J, Wang X, Huang C. miRNA-4317 suppresses human gastric cancer cell proliferation by targeting ZNF322. Cell Biol Int. 2018;42(8):923–930. doi:10.1002/cbin.10870.
[7] Peng Y, Zhang X, Ma Q, et al. MiRNA-194 activates the Wnt/β-catenin signaling pathway in gastric cancer by targeting the negative Wnt regulator, SUFU. Cancer Lett. 2017;385:117–127. doi:10.1016/j.canlet.2016.10.035.
[8] Ganju A, Khan S, Hafeez BB, et al. miRNA nanotherapeutics for cancer. Drug Discov Today. 2017;22(2):424–432. doi:10.1016/j.drudis.2016.10.014.
[9] Duan XM, Liu XN, Li YX, et al. MicroRNA-498 promotes proliferation, migration, and invasion of prostate cancer cells and decreases radiation sensitivity by targeting PTEN. Kaohsiung J Med Sci. 2019;35(11):659–671. doi:10.1002/kjm2.12108.
[10] Chai C, Wu H, Wang B, Eisenstat DD, Leng RP. MicroRNA-498 promotes proliferation and migration by targeting the tumor suppressor PTEN in breast cancer cells. Carcinogenesis. 2018;39(9):1185–1196. doi:10.1093/carcin/bgy092.
[11] Wang Z, Liu J, Wang R, Wang Q, Liang R, Tang J. Long Non-Coding RNA Taurine Upregulated Gene 1 (TUG1) Downregulation Constrains Cell Proliferation and Invasion through Regulating Cell Division Cycle 42 (CDC42) Expression Via MiR-498 in Esophageal Squamous Cell Carcinoma Cells. Med Sci Monit. 2020;26:e919714. Published 2020 Mar 6. doi:10.12659/MSM.919714.
[12] Zhang X, Xu X, Ge G, et al. miR‑498 inhibits the growth and metastasis of liver cancer by targeting ZEB2. Oncol Rep. 2019;41(3):1638–1648. doi:10.3892/or.2018.6948.
[13] Wang M, Zhang Q, Wang J, Zhai Y. MicroRNA-498 is downregulated in non-small cell lung cancer and correlates with tumor progression. J Cancer Res Ther. 2015;11 Suppl 1:C107–C111. doi:10.4103/0973-1482.163859.
[14] Zhang X, Liang W, Liu J, et al. Long non-coding RNA UFC1 promotes gastric cancer progression by regulating miR-498/Lin28b. J Exp Clin Cancer Res. 2018;37(1):134. Published 2018 Jul 3. doi:10.1186/s13046-018-0803-6.
[15] Laphanuwat P, Likasitwatanakul P, Sittithumcharee G, et al. Cyclin D1 depletion interferes with oxidative balance and promotes cancer cell senescence. J Cell Sci. 2018;131(12):jcs214726. Published 2018 Jun 25. doi:10.1242/jcs.214726.
[16] Isoda M, Mikolcevic P, Nebreda AR. New insights into Cdk2 regulation during meiosis. Cell Cycle. 2016;15(20):2681–2682. doi:10.1080/15384101.2016.1204856. Liu Q, Gao J, Zhao C, et al. To control or to be controlled? Dual roles of CDK2 in DNA damage and DNA damage response. DNA Repair (Amst).2020;85:102702.doi:10.1016/j.dnarep.2019.102702.
[17] Mansilla SF, Bertolin AP, Bergoglio V, et al. Cyclin Kinase-independent role of p21CDKN1A in the promotion of nascent DNA elongation in unstressed cells. Elife. 2016;5:e18020. Published 2016 Oct 14. doi:10.7554/eLife.18020
[18] Martinez-Marti A, Navarro A, Felip E. COX-2 inhibitors in NSCLC: never-ending story or misplaced?. Transl Lung Cancer Res. 2018;7(Suppl 3):S191–S194. doi:10.21037/tlcr.2018.04.17.
[19] Liu J, Li X, Huang J, Liu Y. Matrix Metalloproteinase 2 Knockdown Suppresses the Proliferation of HepG2 and Huh7 Cells and Enhances the Cisplatin Effect. Open Med (Wars). 2019;14:384–391. Published 2019 May 17. doi:10.1515/med-2019-0039.
[20] Agarwal V, Bell GW, Nam JW, Bartel DP. Predicting effective microRNA target sites in mammalian mRNAs. Elife. 2015;4:e05005. Published 2015 Aug 12. doi:10.7554/eLife.05005.
[21] Strong VE. Progress in gastric cancer. Updates Surg. 2018;70(2):157–159. doi:10.1007/s13304-018-0543-3.
[22] Zhou J, Ma X, Bi F, Liu M. Clinical significance of circulating tumor cells in gastric cancer patients. Oncotarget. 2017;8(15):25713–25720. doi:10.18632/oncotarget.14879.
[23] Qi R, Wang DT, Xing LF, Wu ZJ. miRNA-21 promotes gastric cancer growth by adjusting prostaglandin E2. Eur Rev Med Pharmacol Sci. 2018;22(7):1929–1936. doi:10.26355/eurrev_201804_14717.
[24] Hu X, Miao J, Zhang M, et al. miRNA-103a-3p Promotes Human Gastric Cancer Cell Proliferation by Targeting and Suppressing ATF7 in vitro. Mol Cells. 2018;41(5):390–400. doi:10.14348/molcells.2018.2078.
[25] Yu L, Zhou GQ, Li DC. MiR-136 triggers apoptosis in human gastric cancer cells by targeting AEG-1 and BCL2. Eur Rev Med Pharmacol Sci. 2018;22(21):7251–7256. doi:10.26355/eurrev_201811_16259.
[26] Liu B, Shyr Y, Cai J, Liu Q. Interplay between miRNAs and host genes and their role in cancer. Brief Funct Genomics. 2018;18(4):255–266. doi:10.1093/bfgp/elz002.
[27] Bach DH, Long NP, Luu TT, Anh NH, Kwon SW, Lee SK. The Dominant Role of Forkhead Box Proteins in Cancer. Int J Mol Sci. 2018;19(10):3279. Published 2018 Oct 22. doi:10.3390/ijms19103279.
[28] Gao F, Tian J. FOXK1, Regulated by miR-365-3p, Promotes Cell Growth and EMT Indicates Unfavorable Prognosis in Breast Cancer. Onco Targets Ther. 2020;13:623–634. Published 2020 Jan 21. doi:10.2147/OTT.S212702.
[29] Lu SR, Li Q, Lu JL, Liu C, Xu X, Li JZ. Long non-coding RNA LINC01503 promotes colorectal cancer cell proliferation and invasion by regulating miR-4492/FOXK1 signaling. Exp Ther Med. 2018;16(6):4879–4885. doi:10.3892/etm.2018.6775.
[30] Li L, Gong M, Zhao Y, Zhao X, Li Q. FOXK1 facilitates cell proliferation through regulating the expression of p21, and promotes metastasis in ovarian cancer. Oncotarget. 2017;8(41):70441–70451. Published 2017 Jul 31. doi:10.18632/oncotarget.19713.
[31] Yang M, Sun S, Guo Y, Qin J, Liu G. Long non-coding RNA MCM3AP-AS1 promotes growth and migration through modulating FOXK1 by sponging miR-138-5p in pancreatic cancer. Mol Med. 2019;25(1):55. Published 2019 Dec 12. doi:10.1186/s10020-019-0121-2.
[32] Zhang P, Tang WM, Zhang H, et al. MiR-646 inhibited cell proliferation and EMT-induced metastasis by targeting FOXK1 in gastric cancer. Br J Cancer. 2017;117(4):525–534. doi:10.1038/bjc.2017.181.
[33] Lu SR, Li Q, Lu JL, Liu C, Xu X, Li JZ. Long non-coding RNA LINC01503 promotes colorectal cancer cell proliferation and invasion by regulating miR-4492/FOXK1 signaling. Exp Ther Med. 2018;16(6):4879–4885. doi:10.3892/etm.2018.6775.
[34] Ji ZG, Jiang HT, Zhang PS. FOXK1 promotes cell growth through activating wnt/β-catenin pathway and emerges as a novel target of miR-137 in glioma. Am J Transl Res. 2018;10(6):1784–1792.